Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir triple therapy immunology study in chronic hepatitis C
NL-OMON39260Active, not recruiting
- Sponsor
- Stichting Maag-, Darm- en Leveronderzoek
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of telaprevir, pegylated interferon alpha and ribavirin in hepatitis C virus infection, sponsored by Stichting Maag-, Darm- en Leveronderzoek. Started May 2012; status: active, not recruiting.
02
Drugs
telaprevirpegylated interferon alpharibavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON39260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39260.